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-Catenin is a neuronal protein that contains 10 Arma-
dillo motifs and binds to the juxtamembrane segment of
 
classical cadherins. We report that 
 
 
 
-catenin interacts
with  cortactin in a tyrosine phosphorylation–dependent
 
manner. This interaction occurs within a region of the
 
 
 
-catenin sequence that is also essential for the neurite
elongation effects. Src family kinases can phosphorylate
 
 
 
-catenin and bind to 
 
 
 
-catenin through its polyproline
 
 
tract. Under conditions when tyrosine phosphorylation is re-
 
duced, 
 
 
 
-catenin binds to cortactin and cells extend un-
branched primary processes. Conversely, increasing tyrosine
phosphorylation disrupts the 
 
 
 
-catenin–cortactin complex.
When RhoA is inhibited, 
 
 
 
-catenin enhances the effects of
Rho inhibition on branching. We conclude that 
 
 
 
-catenin
contributes to setting a balance between neurite elongation
and branching in the elaboration of a complex dendritic tree.
 
Introduction
 
Process elaboration involves a coordinated and complex reper-
toire of cellular systems. The capacity to elaborate processes
has achieved its maximal complexity in neurons, which utilize
the neuronal arbor to increase the number of synaptic contacts,
set the frequency at which impulses spread, and establish
regionally distinct functional outputs (Larkum et al., 1999).
Many extracellular molecules, which affect neurite morphology,
have been identified including secreted factors, plasma
membrane-bound proteins, and proteins bound to the extra-
cellular matrix. However, the intracellular pathways that
control even simple neurite patterning, such as elongation
versus branching, are poorly understood.
Small GTPases, which play a major role in actin organiza-
tion, have been shown to be involved in the regulation of
neuronal cell morphology including neuritogenesis. The role
of RhoA in process formation was first demonstrated in
studies using the Rho-specific ADP-ribosyltransferase C3
toxin (
 
Clostridium botulinum
 
 C3 Rho-ADP–ribosylating
exoenzyme), which could induce neurites in PC12 cells even
without NGF treatment (Nishiki et al., 1990). Many additional
studies have shown that RhoA is involved in the regulation
of neurite outgrowth (Tigyi and Miledi, 1992; Jalink et al.,
1994; Kozma et al., 1997; Zipkin et al., 1997; Lehmann et
al., 1999; Sebok et al., 1999; Nakayama et al., 2000). Studies of
neurite branching often focus on axons; however, dendritic
branching is morphologically distinct from axonal branching
with regard to tapering and branching patterns (Desmond and
Levy, 1984). A role for RhoA in dendritic branching has been
suggested. RhoA activation leads to a reduction in dendritic
branching (Nakayama et al., 2000), and RhoA inhibition
enhances branching (Neumann et al., 2002). Mediators of
RhoA, such as Rho kinase, support these opposite effects on
branching (Katoh et al., 1998). Likewise, Cip1/WAF1 inhibits
Rho kinase and promotes neurite outgrowth and branching
in hippocampal neurons (Tanaka et al., 2002). A distinct
branch of the Rho GTPase family, the Rnd proteins, control
rearrangements of the actin cytoskeleton and changes in
adhesion (Nobes et al., 1998). Rapostlin, an effector for
Rnd2, can induce neurite branching when expressed in
NGF-treated PC12 cells (Fujita et al., 2002). A genetic
screen in 
 
Drosophila
 
 identified several genes that control aspects
of dendrite development including dendritic outgrowth,
branching, and routing (Gao et al., 1999).
Because neuronal process elaboration must involve adhesive
changes concomitant with extension into the neurophil, it is
not surprising that adhesion molecules will be represented in
this molecular toolbox. The p120
 
ctn
 
 family, which consists
of a family of proteins with 10 Armadillo (Arm)* repeats
characteristically spaced, are increasingly recognized for their
dual roles in regulating adhesion and process elaboration.
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Coordinating these two functions is very likely a key role for
the cadherin juxtamembrane sequence where all of these
family members bind. 
 
 
 
-Catenin is a neuronal specific mem-
ber (Ho et al., 2000) of this protein family, which also in-
cludes p120
 
ctn
 
, ARVCF, and p0071. Like p120
 
ctn
 
, 
 
 
 
-catenin
can radically change cell morphology when overexpressed in
fibroblasts (Reynolds et al., 1996; Kim et al., 2002).
The implementation of process elaboration requires reor-
ganization of the actin cytoskeleton, and indeed linkages be-
tween the adherens junction and the actin cytoskeleton are
well recognized. 
 
 
 
-Catenin binds both to the COOH termi-
nus of classical cadherins and to 
 
 
 
-catenin, which binds di-
rectly or indirectly to actin (Yamada and Geiger, 1997). A
second linkage through the p120
 
ctn
 
 family of proteins can be
surmised based on functional studies, but the actual compo-
nents or pathway is unknown. Potentially, most informative
is the extension of data derived for p120
 
ctn
 
 to 
 
 
 
-catenin. Like
 
 
 
-catenin, p120
 
ctn
 
 induces a “branching phenotype” (Rey-
nolds et al., 1996; Kim et al., 2002). An interaction between
p120
 
ctn
 
 and Rho1 and an accumulation of Rho1 in adherens
junctions occurs in 
 
Drosophila
 
 (Magie et al., 2002). p120
 
ctn
 
inhibits Rho (Anastasiadis et al., 2000; Noren et al., 2000), and
cadherin binding to p120
 
ctn
 
 functions as a regulator of adhe-
sion through Rho GTPases (Anastasiadis and Reynolds, 2001).
Cortactin is a linker protein to the actin cytoskeleton,
which is well suited to couple tyrosine kinase signaling be-
tween membrane proteins and the cytoskeleton (Weed and
Parsons, 2001). A centrally positioned series of repeats in
cortactin bind and cross-link actin filaments in a tyrosine
phosphorylation–dependent manner (Wu and Parsons, 1993;
Huang et al., 1997). Through binding to the Arp2/3 com-
plex, cortactin provides a site for actin filament nucleation
(Weed et al., 2000; Uruno et al., 2001). Additionally, Rho
GTPases can determine cortactin association with the actin
system and contractile regulation in endothelial cells (Garcia
et al., 1999). Here, we show that 
 
 
 
-catenin binds cortactin
in a tyrosine phosphorylation–dependent manner that de-
pends on Src family kinases. Inhibition of these kinases en-
ables 
 
 
 
-catenin–cortactin complex formation and the growth
of primary neurites. On the other hand, inhibition of the
RhoA pathway together with expression of 
 
 
 
-catenin further
enhances the extension of secondary neurites. 
 
 
 
-Catenin ap-
pears positioned to regulate neurite growth through two sep-
arate pathways that balance primary process extension with
branch formation.
 
Results
 
 
 
-Catenin induces neurites
 
A prominent effect of 
 
 
 
-catenin on cells is process elabora-
tion. PC12 cells treated with NGF (100 ng/ml) at the time
of GFP–
 
 
 
-catenin transfection extended unbranched pri-
mary processes 36 h later (Fig. 1 A). When transfected with
GFP alone, treatment of PC12 cells with NGF for the rela-
tively short time of 36 h induced very short processes in a
small percentage of the cells, whereas most of the cells re-
mained rounded (Fig. 1 A). About 20% of GFP–
 
 
 
-catenin–
transfected cells elaborated processes, which were longer
than one cell body in length, whereas none of the cells trans-
fected with GFP alone had processes that extended one cell
body or more. Due to the variation in expression levels in
the transient transfections and the general inhibition of pro-
cess elaboration by acute transfections, we repeated these ex-
periments in a PC12 cell line that stably expresses 
 
 
 
-catenin
(
 
 
 
-PC12 cells). These cells extended long relatively un-
branched processes after a 36-h treatment with NGF (Fig. 1
B). Not surprisingly the 
 
 
 
-PC12 cells displayed more
uniform morphological changes. Comparing NGF-treated
 
 
 
-PC12 cells with NGF-treated wild-type PC12 cells, we
found that the mean number of primary processes increased
from 2.7 
 
 
 
 0.14 to 3.5 
 
 
 
 0.21 (P 
 
  
 
0.005), and the total
summed length of all processes increased from 12.80 
 
 
 
 1.05
to 20.5 
 
 
 
 1.7 
 
 
 
m (P 
 
 
 
 0.001) (Fig. 1 B). Both NGF-
treated 
 
 
 
-PC12 cells and NGF-treated wild-type PC12 cells
had very few secondary processes, and their numbers did not
statistically differ (Fig. 1 B).
Transfection of 
 
 
 
-catenin into cultured hippocampal neu-
rons at 9 d in vitro also alters cell morphology (Fig. 2 A). In-
terestingly, the induced growth was restricted to dendrites
even though transfected 
 
 
 
-catenin extended through the en-
tire neuron as detected by the GFP label. The outgrowths
induced by 
 
 
 
-catenin were thin processes of uniform caliber
that emerged from the distal dendritic tree and varied greatly
in length (Fig. 2, A and C). These processes created a sense
of exaggerated filopodial protrusions, and like filopodia they
Figure 1.  -Catenin induces branching in PC12 cells. (A) GFP (a) 
and GFP- -catenin constructs (b) transfected in PC12 cells. Cells 
were fixed 36 h after transfection, and NGF was added at the time 
of the transfection. Bar, 5  m. (B) PC12 cells (a) and  -PC12 cells (b) 
were treated with NGF for 36 h. Cells were fixed and stained for 
actin. Quantification of the total process length and the number of 
primary and secondary processes is shown for PC12 and  -PC12 
cells after 36 h of NGF treatment. Bar, 5  m.T
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were labeled for actin but not for tubulin or MAP2 (Fig. 2
B). Both the length and number of protrusions in the most
distal dendrites of 
 
 
 
-catenin–transfected neurons increased
when compared with GFP-transfected cells (Fig. 2 C). For
 
 
 
-catenin–transfected neurons, the mean length of the pro-
trusions was 3.32 
 
 
 
 0.37 
 
 
 
m, and there were 10.5 
 
 
 
 0.72
protrusions over a 25-
 
 
 
m dendritic segment. For GFP-
transfected neurons, the mean length of the protrusions was
1.67 
 
 
 
 0.17 
 
 
 
m, and there were 5.16 
 
 
 
 0.87 protrusions
over a 25-
 
 
 
m dendritic segment. These differences were
highly significant (P 
 
  
 
0.001) (Fig. 2 C). Staining of GFP
and GFP–
 
 
 
-catenin–transfected neurons for actin showed
the extension of the signal into all the protrusions (unpub-
lished data).
 
 
 
-Catenin deletion constructs (Fig. 3 A) were used to de-
fine a sequence essential for process elaboration. 
 
 
 
-Catenin
construct 
 
 
 
C205 (numbers refer to the number of aa de-
leted from the COOH terminus) completely failed to in-
duce morphological changes when transfected into PC12
cells or primary neurons (Fig. 3 B). However, 
 
 
 
C99 in-
duced effects similar to those observed for GFP–full-length
 
 
 
-catenin construct (Fig. 3 B) in both cell types. The 
 
 
 
C332
deletion extended into the Arm repeat domain, and there-
fore, this construct did not localize to the plasma membrane,
as occurs with full-length, transfected 
 
 
 
-catenin and endoge-
nous 
 
 
 
-catenin, and did not induce morphological changes
(unpublished data). The failure of this construct to induce
processes is presumably due to its incorrect localization.
Figure 2.  -Catenin induces protrusions along the distal dendritic shafts 
of hippocampal neurons. (A) Rat hippocampal neurons in culture for 
8 d were transfected with GFP (a) and GFP– -catenin constructs (b) and 
fixed 24 h later. Small branches and filopodial-like protrusions on 
dendrites are indicated by arrows in b. Bar, 15  m. (B) Hippocampal 
neurons in culture for 8 d were transfected with GFP– -catenin (d–f) 
and stained for MAP2 (a), actin (b), and tubulin (c). Panels g–i show 
colocalization. Bar, 5  m. (C) Quantification of the number and length 
of protrusions for GFP and GFP– -catenin–transfected neurons. Detail 
of the protrusions is shown for GFP- (a) and GFP– -catenin– (b) transfected 
neurons. Bar, 5  m.T
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However, 
 
 
 
C205, which includes all of the Arm repeats but
deletes nearly the entire COOH terminus beyond the re-
peats, did localize in membrane patches similar to full-
length, transfected 
 
 
 
-catenin and to a construct with only
the Arm repeats (unpublished data) but was unable to in-
duce any of the morphological changes described for the
full-length protein (Fig. 3 B). Together, these deletion con-
structs suggested a region of 105 aa in the COOH terminal
region of 
 
 
 
-catenin that was essential for process elaboration.
 
 
 
-Catenin is linked to cortactin
 
Immunostaining with 
 
 
 
-catenin antibodies demonstrated
that the endogenous protein is coextensive with filamentous
actin (Fig. 4 A). This association was most obvious in neu-
ronal growth cones. Among the candidate proteins which
could link 
 
 
 
-catenin to actin is cortactin. Like 
 
 
 
-catenin,
cortactin is present in growth cones (Du et al., 1998) and in
the postsynaptic density (Naisbitt et al., 1999). Several
observations support the existence of a 
 
 
 
-catenin–cortac-
tin complex. First, cortactin colocalized with 
 
 
 
-catenin in
growth cones of young neurons and in spines of 3-wk-old
primary neurons (Fig. 4 A). Moreover, endogenous cortac-
tin coimmunoprecipitated with 
 
 
 
-catenin in 3-d-, 7-d-, and
4-wk-old cultured hippocampal neurons (Fig. 4 B). Hip-
pocampal primary neurons were lysed and immunoprecipi-
tated with polyclonal 
 
 
 
-catenin antibody (Ab62) and an
unrelated antibody as a negative control. The reverse co-
immunoprecipitation was done with a polyclonal antibody
for cortactin (see Materials and methods). The amount of
both 
 
 
 
-catenin and cortactin increases with the age of the
neurons when starting with the same initial number of neu-
rons. Cortactin antibody coimmunoprecipitated a small
fraction of the total  -catenin (Fig. 4 B). When COS1 cells
were transfected with GFP– -catenin and cortactin–Flag,
the two proteins coimmunoprecipitated with a  -catenin
polyclonal antibody (Fig. 4 C). A FLAG antibody also
coimmunoprecipitated  -catenin when both proteins were
coexpressed in COS1 cells (Fig. 4 C). And, finally GST–
cortactin but not GST alone pulled down endogenous
 -catenin from 6-d-old and 4-wk-old cultured neurons. A
positive control indicated that cortactin also pulled down
actin (Fig. 4 D).
To determine the region in  -catenin where cortactin
binds, each of the  -catenin deletion constructs (Fig. 3 A)
was transfected into COS1 cells and pulled down with
GST–cortactin (Fig. 5 A). A deletion of 99 aa from the
 -catenin COOH terminal ( C99) retained the ability to
interact with cortactin in the pull-down assay (Fig. 5 A).
However GST–cortactin was not able to pull down  C205
and pulled down only trace amounts of  C332 (Fig. 5 A).
To rule out a potential binding interaction through the SH3
domain in cortactin and the NH2-terminal polyproline tract
in  -catenin that might have been obscured in the COOH-
terminal deletions, FL  P6, which deletes the  -catenin
polyproline track (aa 219–224), was used (Fig. 3 A). This
construct was pulled down by GST–cortactin (Fig. 5 B). To
confirm this observation, a COOH-terminal fragment of
cortactin (aa 267–509) containing the SH3 domain fused to
GST (Fig. 3 B) was used for a pull-down assay with  -cate-
nin (Fig. 5 B). Neither this construct nor GST alone pulled
down  -catenin or  C99 constructs, suggesting that the in-
teraction was not via an SH3 domain. Together, these data
suggest that approximately the same region that is required
for  -catenin–induced processes also binds cortactin.
Tyrosine phosphorylation of  -catenin
The tyrosine phosphorylation state of  -catenin in  -PC12
cells and primary neurons differed.  -Catenin was tyrosine
phosphorylated in the  -PC12 cells (Fig. 6 A), and NGF did
not alter the phosphotyrosine immunoreactivity (unpub-
lished data). In contrast, tyrosine phosphorylation was not
detected on  -catenin in the primary neurons (Fig. 6 B).
Figure 3. The COOH terminus of 
 -catenin is necessary for neurite 
formation. (A) Schematic representation 
of  -catenin and cortactin deletion 
constructs. (a)  -Catenin deletion 
constructs fused to GFP (as described 
in Materials and methods). Constructs 
are named by the number of amino 
acids deleted from the COOH terminus. 
(b) Schematic representation of the 
cortactin GST fusion constructs. 
(B) Hippocampal neurons in culture 
for 8 d (a) and NGF-treated PC12 
cells (b) were transfected with the GFP, 
FL ,  C205, and  C99 constructs. 
Quantification of the number and 
length of protrusions for the hippocampal 
neurons and the number of primary 
branches and total summed length of all 
processes for PC12 cells are shown.T
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Figure 4.  -Catenin associates with actin and cortactin in 
hippocampal neurons. (A) Hippocampal neurons in culture for 
5–7 d (a–h) or 3 wk (i–l) were double labeled with a mAb  -catenin 
(green) and either phalloidin (red, a–d) or cortactin (red, e–l). Boxed 
areas in a, e, and i are shown at high power in images below. Panels 
b, f, and j show the red labels, and panels c, g, and k show the 
green labels. Colocalization in yellow is shown in panels a, e, and 
i for the low magnification images and in panels d, h, and l for the 
high magnification images. Bar: (a, e, and i) 50  m; (the remaining 
images) 5  m. (B)  -Catenin coimmunoprecipitates with cortactin 
in hippocampal neurons. Hippocampal neurons plated for 3 d,
7 d, and 4 wk were lysed and immunoprecipitated with  -catenin 
pAb 62 or with an unrelated antibody mAb (HA). The immuno-
complexes were sequentially immunoblotted with a cortactin 
antibody and mAb  -catenin. Hippocampal neurons plated for 
9 d were reverse immunoprecipitated with a cortactin antibody 
or with mouse IgG as negative control. Complexes were 
immunoblotted with cortactin and mAb  -catenin antibodies. 
(C) Coimmunoprecipitation of  -catenin and cortactin cotransfected into COS1 cells. Cells were lysed, and immunoprecipitation was performed 
with pAb anti– -catenin 62 or anti-mAb HA. Transfection of  -catenin alone into COS1 cells shows that the  -catenin bands comigrate. For a 
reverse coimmunoprecipitation, the cotransfected COS1 cells were immunoprecipitated with an anti-mAb Flag antibody or anti-mAb HA as 
negative control. Transfection of Flag–cortactin alone into COS1 cells shows that the Flag–cortactin bands comigrate. Blots were visualized 
with cortactin and mAb  -catenin antibodies. (D) GST–cortactin pulls down  -catenin from hippocampal neurons. Pull down with GST and 
GST–full-length cortactin (GSTCort) was performed in lysates from hippocampal neurons plated for 6 d or 4 wk. Cell lysates were incubated with 
glutathione sepharose beads bound to GST or GST–cortactin fusion constructs. Beads were eluted in SDS buffer and loaded for electrophoresis. 
Blots were visualized with mAb  -catenin or actin antibody.
The tyrosine phosphorylation of many proteins can be in-
creased by pretreatment with H2O2 (200  M) and ortho-
vanadate (1 mM), which inhibit phosphatases. In primary
neurons, H2O2 induced the tyrosine phosphorylation of
 -catenin, and H2O2 plus orthovanadate further increased
the tyrosine phosphorylation (Fig. 6 B). The tyrosine phos-
phorylation of cortactin also increased after H2O2 treatment
as reported (Li et al., 2000).
Inspection of the  -catenin sequence indicates multiple
consensus sites for tyrosine phosphorylation within the re-
gions that flank the Arm repeats. In the sequence which is
COOH terminal to the last Arm repeat there are 17 tyro-T
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sines. Mutation of various combinations of these tyrosines to
phenylalanine including the single tyrosine at position
1,041, which is conserved in ARVCF and p120ctn, did not
alter the intensity of the signal detected by a phosphoty-
rosine antibody in cultures transfected with mutant and
wild-type constructs at equal transfection efficiencies (un-
published data). It is likely that the COOH terminus con-
tains multiple tyrosine phosphorylation sites.
 -Catenin is a Src family substrate
To determine the family of tyrosine kinases responsible for
phosphorylating  -catenin,  -PC12 cells were treated with
several tyrosine kinase inhibitors. We found that a treatment
with PP2 (25  M), a Fyn/Lck/Hck tyrosine kinase inhibitor
(Fig. 7 A), was able to abolish endogenous  -catenin phos-
phorylation in  -PC12 cells. Nonreceptor tyrosine kinases
are good candidates because p120
ctn is a known Src substrate
(Kanner et al., 1991; Reynolds et al., 1992) and  -catenin is
an in vitro substrate for Abl (Lu et al., 2002). In  -PC12
cells, the basal level of tyrosine phosphorylation on  -cate-
nin can be completely inhibited by PP2 (Fig. 7 A). In pri-
mary cultured neurons, endogenous  -catenin is only mini-
mally tyrosine phosphorylated, but after H2O2 treatment,
which can induce tyrosine phosphorylation of  -catenin
(Fig. 6 B), 25  M PP2 completely inhibited  -catenin tyro-
sine phosphorylation as detected by a phosphotyrosine anti-
body (Fig. 7 A). When Fyn was transfected into  -PC12
cells,  -catenin phosphorylation increased (Fig. 7 B), but en-
dogenous phosphorylation was not abolished when a domi-
nant-negative form of Fyn (Fyn K299M) was transfected,
raising the possibility that other members of the Src family
phosphorylate   -catenin. Several  -catenin deletion con-
structs were tested for H2O2-induced tyrosine phosphoryla-
tion, and the specific constructs on which tyrosine phosphor-
ylation was induced by H2O2 matched the constructs on
which Fyn transfection induced tyrosine phosphorylation
(unpublished data). In addition to serving as a substrate for a
Src family tyrosine kinase, a Fyn–SH3–GST construct and a
Lck–SH3–GST construct pulled down  -catenin in trans-
fected COS1 cells and in neurons (Fig. 7 C). Neither Fyn–
SH3 nor Lck–SH3 pulled down FL  P6, a  -catenin
construct which lacked the polyproline track (Fig. 7 C). To-
gether, this data suggest that a Src family nonreceptor ty-
rosine kinase binds to  -catenin through its polyproline tract
and phosphorylates  -catenin.
Tyrosine phosphorylation regulates 
the  -catenin–cortactin interaction
In contrast to primary neurons, the  -catenin–cortactin
complex was not observed in  -PC12 cells under basal con-
ditions presumably due to the difference in the basal tyro-
sine phosphorylation state between these cells and primary
neurons. To test the hypothesis that tyrosine phosphoryla-
tion regulates the  -catenin–cortactin interaction, we deter-
mined whether PP2 treatment, which can abolish tyrosine
phosphorylation of  -catenin in  -PC12 cells, could restore
the interaction. Indeed, when  -PC12 cells (pretreated with
100 ng/ml NGF for 36 h) were exposed to PP2 (25  M) for
1 h the formation of the  -catenin–cortactin complex was
detected (Fig. 6 D).
We next asked whether the activation of tyrosine phos-
phorylation in primary neurons could induce the dissocia-
tion of the  -catenin–cortactin complex. When primary
neurons were treated with H2O2 for 5 min or with H2O2
Figure 5. Cortactin binds to the COOH terminal region of  -catenin. 
(A) COS1 cells were transfected with GFP– -catenin (FL ),  C99 
(top),  C205 (middle), and  C332 (bottom) constructs. Transfected 
cells were lysed and subjected to pull down with GST and GST–
cortactin (GSTCort) constructs. (B) COS1 cells were transfected 
with either full-length  -catenin (Fl ) or a full-length construct from 
which the polyproline tract was deleted (FL  P6), pulled down with 
GST or GST–cortactin, and blotted with mAb  -catenin (top). COS1 cells were transfected with FL  or  C99 and pulled down with GST or 
GST-cortactin, or GST–CTcortactin (GSTCtCort, aa 287–509 of cortactin), which retains the SH3 domain (bottom).T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
  -Catenin and neuronal morphogenesis | Cruz Martinez et al. 105
(200  M) plus orthovanadate (1 mM), the interaction
between cortactin and  -catenin was abolished (Fig. 6
B), whereas the  -catenin–N-cadherin interaction was pre-
served. This observation suggested that the  -catenin–cortac-
tin interaction depends on the tyrosine phosphorylation state
Figure 6.  -Catenin–cortactin interaction is regulated by tyrosine 
phosphorylation. (A) PC12 and  -PC12 cells were lysed and immuno-
precipitated with mAb  -catenin. Blots were immunolabeled with a 
mAb  -catenin or a phosphotyrosine antibody (p-tyr). (B) Hippocampal 
neurons in culture for 10 d were treated for 5 min with 200  M H2O2 
or 200  M H2O2 plus 1 mM sodium orthovanadate. Cells were 
lysed and immunoprecipitated by a mAb  -catenin. Blots were 
immunolabeled for mAb  -catenin, phosphotyrosine, cortactin, and 
N-cadherin. (C) Hippocampal neurons in culture for 3 wk were treated 
with BDNF (50 ng/ml) for 1 h, and  -catenin was immunoprecipitated 
with a mAb  -catenin. Blots of the immunoprecipitated products 
were labeled with mAb  -catenin, phosphotyrosine, and cortactin 
antibodies. (D)  -PC12 cells (pretreated with 100 ng/ml NGF for 
36 h) were treated with PP2 (25  M for 1 h). Immunoprecipitated 
products were blotted with mAb  -catenin, phosphotyrosine, and 
cortactin antibodies.
Figure 7. Tyrosine phosphorylation of  -catenin. (A)  -PC12 cells 
(pretreated with NGF for 36 h) and hippocampal neurons were treated 
with 25  m PP2 for 1 h; additionally, hippocampal neurons were 
treated with 200  M H2O2 for 5 min,  -catenin was immuno-
precipitated with a mAb  -catenin, and its phosphorylation state 
was tested with antiphosphotyrosine. (B)  -PC12 cells were transfected 
with constructs corresponding to Fyn or a dominant-negative Fyn 
(FynK299M). Cells were lysed, and lysates were subjected to immuno-
precipitation with a mAb  -catenin. The immunocomplexes were 
sequentially immunoblotted with a mAb  -catenin and a phospho-
tyrosine antibody. (C) In the top panel, COS 1 cells were transfected 
with FL  or FL  P6. Cell lysates were incubated with GST–SH3Lck 
and GST–SH3Fyn fusion proteins bound to glutathione-sepharose 
beads. Lysates incubated with glutathione beads alone served as a 
control. In the bottom panel, GST–SH3Lck and GST–SH3Fyn fusion 
proteins bound to glutathione sepharose beads, or beads alone were 
incubated with lysates from 3-wk-old hippocampal neurons. In all 
lanes, eluted proteins were blotted with a mAb  -catenin.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
106 The Journal of Cell Biology | Volume 162, Number 1, 2003
of the cell and possibly on the tyrosine phosphorylation state
of  -catenin and/or cortactin. Interestingly, treatment of the
hippocampal neurons with brain-derived neurotrophic fac-
tor (BDNF) (50 ng/ml) for 60 min also induced  -catenin
phosphotyrosine immunoreactivity and dissociation of the
 -catenin–cortactin complex (Fig. 6 C). Thus, two different
cell types, primary neurons and  -PC12 cells, with different
basal levels of  -catenin tyrosine phosphorylation have con-
sistent  -catenin–cortactin complex association or dissocia-
tion in response to increasing or decreasing their state of ty-
rosine phosphorylation.
Primary process elongation versus branching
The inhibition of  -catenin tyrosine phosphorylation in
NGF-treated  -PC12 cells exposed to PP2 (25  M for 1 h)
enhanced the morphological changes induced by  -catenin
(Fig. 8). The total length of the processes increased from
15.1   1.2 to 24.9   2.4  m (P   0.0001), and the num-
ber of primary processes increased from 3   0.26 to 5.1  
0.37 (P   0.0001), but there was no change in the number
of branches or secondary processes (Fig. 8 B). Wild-type
PC12 cells, which have negligible if any  -catenin, were un-
affected by PP2 (unpublished data).
The pattern of  -catenin process elaboration could be
qualitatively changed when PC12 cells, treated with NGF
for 36 h, also expressed the C3 exotoxin, a specific Rho GTP-
ase inhibitor derived from C. difficile, which inhibits Rho by
ADP ribosylation (Boquet, 1999).  -Catenin greatly en-
hanced the elaboration of branches induced by Rho inhibi-
tion (Fig. 9, A and B). In PC12 cells cotransfected with GFP
and C3 versus GFP-transfected PC12 cells, there was a two-
fold increase in the number of primary processes and a 3.8-
fold increase in the number of secondary processes.  -PC12
cells cotransfected with C3 and GFP compared with  -PC12
cells transfected with GFP showed a twofold increase in the
number of primary processes and 9.2-fold increase in the
number of secondary processes. When compared, the relative
increase of secondary processes in  -PC12 cells compared
with PC12 cells was significant (Fig. 9 B). Because the sec-
ondary branches were usually quite short, the increased num-
ber of secondary branches did not significantly change the
total summed length of the neurites. Thus, the inhibition of
Rho GTPase with C3 changed the effect of  -catenin on cell
morphology from primary process extension to branch for-
mation. In contrast, coexpression of a dominant-active Rho
(V14-RhoA mutant) completely inhibited any  -catenin–
induced process formation (Fig. 9 A). The effect of C3 oper-
ates through Rho kinase as determined by the observation
that the Rho kinase inhibitor Y27632 had a nearly identical
effect as C3 in enhancing  -catenin–induced branch forma-
tion (Fig. 9 B). Coexpression of the dominant-negative N17
mutants of Rac1 or Cdc42 or the dominant-active V12 mu-
tants of Rac1 or Cdc42 with  -catenin in PC12 cells had
minimal morphological effects beyond the effects of  -cate-
nin alone (unpublished data). Inhibition of Rho in conjunc-
tion with  -catenin greatly enhanced branching, whereas
inhibition of tyrosine phosphorylation enhanced primary
process extension. The independence of these growth path-
ways was supported by the finding that treatment of  -PC12
cells with Y27632 did not induce the formation of  -cate-
nin–cortactin complexes despite the competency of these
cells to elaborate branched processes (unpublished data).
The augmentation of branching by  -catenin through Rho
inhibition in contrast to the effects of inhibiting tyrosine ki-
nases was even more apparent in the primary neurons (Fig. 9
C). C3 exotoxin had minimal effects on primary cultured neu-
rons taken from embryonic day 18 rat hippocampus, but when
cotransfected with  -catenin C3 markedly exaggerated growth
(Fig. 9 C). A profusion of new branches occurred over the en-
tire dendritic tree rather than being confined to the more distal
dendritic tree as occurred with  -catenin expression alone. The
increased branching may be due to de novo formation of
branches or extension of preexisting filopodia. The length of
the protrusions in the distal dendrites was significantly in-
creased in  -catenin–C3–transfected neurons (5.6   0.7  m)
compared with  -catenin–transfected alone (3.2   0.37  m)
(P   0.005). The number of protrusions in a 25- m dendritic
segment was 13.8   0.65 in  -catenin–C3–transfected cells
compared with 10.5   0.62 in  -catenin–transfected cells
(P     0.006). In GFP-transfected control cells, the average
length of the protrusions was 1.67   0.17  m, and C3 trans-
fection did not cause a significant change (1.47   0.11  m).
GFP-transfected cells and GFP–C3-transfected cells show an
average of approximately five protrusions per 25- m dendritic
segment (5.16   0.87 and 5   0.7, respectively). In the case of
RhoV14, we observed a simplification of the dendritic tree as
described previously (Nakayama et al., 2000). Transfection of
 -catenin together with Rho V14 caused a significant decrease
in the length of the protrusions (1.3   0.12  m) compared
with   -catenin–transfected cells (P    0.001).   -Catenin–
RhoV14–cotransfected cells had an average of (6   0.65) pro-
trusions in a 25- m dendritic segment, which differed signifi-
cantly from cells transfected with  -catenin alone (P   0.001).
Figure 8. Inhibition of Src family kinases enhances  -catenin–
induced primary process elongation. (A)  -PC12 cells were treated 
with 100 ng/ml NGF for 36 h and then left untreated (a) or treated 
with PP2 for 1 h (b). Cells were labeled with a mAb  -catenin. Bar, 
5  m. (B) Quantification of neurite length and number of primary 
and secondary processes before and after PP2 treatment. No secondary 
processes were observed in the absence or presence of PP2.T
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Dendrites of GFP–RhoV14-transfected neurons were com-
pletely retracted. Unlike Rho, coexpression of the dominant-
negative N17 mutants of Rac1 or Cdc42 or the dominant-
active V12 mutants of Rac1 or Cdc42 with  -catenin in
cultured hippocampal neurons had minimal additional mor-
phological effects (unpublished data). The independence of the
Rho inhibition and the tyrosine kinase inhibition growth path-
ways was supported by the finding that treatment of the pri-
mary neurons with LPA (10  M for 10 min or 1 h), which ac-
tivates RhoA (Tigyi et al., 1996), did not dissociate the
 -catenin–cortactin complex (unpublished data).
Discussion
Tyrosine phosphorylation of  -catenin–cortactin 
complex by an Src family kinase
 -Catenin is capable of inducing process elongation and
branching, both of which require a reorganization of the ac-
Figure 9. Inhibition of Rho in the presence of  -catenin enhances branch formation. (A) PC12 cells treated with NGF for 36 h were transfected 
with GFP (a), GFP and RhoV14 (b), GFP and C3 exotoxin (c). A second set of NGF-treated PC12 cells were transfected with GFP– -catenin 
(d), GFP– -catenin plus RhoV14 (e), or GFP– -catenin plus C3 exotoxin (f). Note the small branches in GFP– -catenin–C3-transfected cells 
(f, arrows). Bar, 5  M. (B, a) PC12 and  -PC12 cells transfected with GFP alone or cotransfected with GFP and C3 exotoxin. Neurite length 
and number of primary and secondary processes of C3-treated cells were quantified and expressed relative to those of untreated cells. 
(b) GFP-transfected PC12 and  -PC12 cells were treated with the Rho kinase inhibitor Y27632 (10  M) for 1 h before fixation. Total process 
length and number of primary and secondary processes were quantified relative to those of untreated cells. (C) Hippocampal neurons plated 
for 8 d were transfected with GFP– -catenin (d), GFP– -catenin plus RhoV14 (e), or GFP– -catenin plus C3 (f). As control, GFP (a), GFP plus 
RhoV14 (b), and GFP plus C3 (c) were transfected. Cells were fixed 24 h after transfection. Bar, 15  M. Quantification of the length and number 
of protrusions with asterisks indicating significant differences relative to transfections with  -catenin alone indicated by GFP- .T
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tin cytoskeleton. A sequence near the COOH terminus of
 -catenin just carboxy to the Arm repeats is required for these
morphologic changes. This same region of  -catenin binds
to cortactin, and the data presented here suggested that the
interaction is responsible for primary process extension. In
support of this mechanism is the finding that constructs
which lack the ability to bind cortactin cannot induce pro-
cesses when transfected into PC12 cells or into primary neu-
rons (Fig. 3). Thus, a functional property of  -catenin maps
to the same region as that of cortactin binding, making it
likely that cortactin binding is required for some of the mor-
phologic changes induced by  -catenin.
The interaction between  -catenin and cortactin is me-
diated by tyrosine phosphorylation as suggested by dissoci-
ation of the complex with increased Src family tyrosine
kinase activity. Both  -catenin and cortactin can be ex-
tensively tyrosine phosphorylated. Indeed, many proteins
that are tyrosine phosphorylated by Src kinase family
members are involved in actin organization including
ezrin-radixin-moesin proteins, p120
ctn,  -catenin, tensin,
focal adhesion kinase, Crk-associated substrate, and actin
filament–associated protein (Kanner et al., 1990). More-
over, cortactin directly and specifically binds endothelial
cell myosin light chain kinase, and the interaction can be
regulated by Src-mediated tyrosine phosphorylation of ei-
ther protein (Dudek et al., 2002). Tyrosine phosphoryla-
tion of the potassium channel Kv1.2 also regulates its
binding to cortactin (Hattan et al., 2002).
Positioned at a membrane proximate site,  -catenin can
influence dynamic cortical actin assembly through its re-
cruitment of cortactin (Weed et al., 2000) in a phosphoryla-
tion-dependent manner. One potential role of the  -cate-
nin–cortactin interaction is to modulate the effects of
cortactin on Arp2/3 actin polymerization. The Arp2/3 com-
plex, comprising seven polypeptides, regulates both the for-
mation and structure of actin networks directly (May,
2001). By dramatically increasing the nucleation rate, the
Arp2/3 complex generates the large number of new fila-
ments needed for actin network formation and helps create
the branched network by cross-linking the slow growing
pointed end of one filament to the side of another. How-
ever, Arp2/3 complex–mediated cross-links are relatively la-
bile, and cortactin may stabilize Arp2/3 complex–mediated
branches (Weaver et al., 2001). The role of cortactin and
Arp2/3 complex in modulating the neuronal cytoskeleton in
favor of neurite outgrowth is poorly understood, but  -cate-
nin could serve to localize protrusions to sites of neuronal
activity. Both proteins also interact with postsynaptic scaf-
folding proteins: SHANK in the case of cortactin (Naisbitt
et al., 1999) and S-SCAM in the case of  -catenin (Ide et al.,
1999). Multiple possibly redundant pathways leading to
neurite extension converge around the Src kinase–mediated
cortactin interactions. These include N-syndecan, a neurite
outgrowth receptor that can bind the nonreceptor tyrosine
kinase Src and its substrate, cortactin (Kinnunen et al.,
1998), and the neural Wiskott-Aldrich syndrome protein
Figure 10.  -Catenin and primary process extension versus branching. Two different pathways regulate the effects of  -catenin on process 
elaboration. Extracellular signals such as neurotrophins acting through regulation of Src family kinases can lead to  -catenin–cortactin complex 
formation. The complex becomes competent to participate in primary process elongation by recruiting the Arp2/3 complex. Rho inhibition 
can be amplified by  -catenin, which leads to branching.T
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(N-Wasp), which plays an essential role in neurite extension
in PC12 cells and rat hippocampal primary culture cells
(Banzai et al., 2000). N-Wasp and cortactin can bind simul-
taneously to the Arp2/3 complex and activate actin assembly
(Weaver et al., 2002).
Modulation of neurite complexity
A balance between process elongation and branching is criti-
cal for the cell to achieve its ultimate shape. These two mor-
phologic phenotypes may operate by distinct but not neces-
sarily autonomous signaling pathways. Extensively branched
processes regulated by Rho or primary process extension with
minimal secondary branching regulated by Src are both in-
duced in association with  -catenin expression (Fig. 10).
When Rho is inhibited, processes tend to branch, and when
Src family tyrosine kinase activity is reduced, processes elon-
gate without branching (Fig. 10). The ability of  -catenin to
enhance the effect of C3 could imply that C3 incompletely
inhibits Rho-related proteins and  -catenin allows further in-
hibition (indeed p120
ctn potently inhibits RhoA), or  -cate-
nin affects related pathways similar to the ability of p120
ctn
to increase the activity of endogenous Cdc42 and Rac1
(Noren et al., 2000). A signaling node where these effects
might be coordinated is through p190RhoGAP. The activity
of some regulators of Rho such as p190RhoGAP can be
modified by Src family phosphorylation (Arthur et al., 2000;
Brouns et al., 2001). Stimuli that activate Src might modu-
late both pathways. An increase in tyrosine kinase as induced
by H2O2 would have convergent inhibitory effects on process
elaboration by both relieving the inhibition on Rho activity
and dissociating the cortactin– -catenin complex. Under
more physiologic circumstances, these effects might be regu-
lated by neurotrophins, which can abolish Rho activation
when bound to p75 receptor (Dailey and Smith, 1996) and,
in the case of BDNF, activate Fyn kinase (Narisawa-Saito et
al., 1999) via the TrkB receptor. Thus,  -catenin is well posi-
tioned to mediate a balance between process elongation and
branching: when Rho is inhibited processes tend to branch
and when Src family tyrosine kinase activity is reduced pro-
cesses elongate without branching (Fig. 10). The relative bal-
ance of these activities may mediate process morphology.
Materials and methods
Cell culture and transfection
A stable  -PC12 cell line was described previously (Lu et al., 2002), and
PC12 cells were obtained from American Type Culture Collection. PC12
cell transfections used Lipofectamine 2000 (Invitrogen, Inc.). For the estab-
lishment of hippocampal cultures, embryos were removed from embry-
onic day 18 Sprague Dawley rats, and cultures were established as de-
scribed (Rook et al., 2000). Primary hippocampal neurons were transiently
transfected using Lipofectamine 2000. The media of cultures varying from
7 to 9 d in vitro was changed to DME containing 1 mM sodium kynurenate
and 10 mM MgCl2, and cultures were incubated for 30 min at 37 C/5%
CO2. During this incubation, 3  l of lipofectamine was mixed with 150  l
of serum-free medium and added to a mixture of 150  l serum-free me-
dium plus 3  g DNA. Precipitates were allowed to form during 20 min and
were added drop wise to 25-mm coverslips. Cells were incubated at 37 C/
5% CO2 during 2 h and returned to conditioned Neurobasal medium.
Immunofluorescence
For immunostaining, neurons cultured on coverslips were washed once in
PBS and fixed with 4% PFA in PBS for 15 min RT, washed twice in PBS,
and then permeabilized for 5 min in PBS containing 0.2% Triton X-100.
Cells were washed twice in PBS, blocked in 10% normal goat serum for 30
min RT and exposed to primary antibodies in PBS containing 1% normal
goat serum overnight at 4 C. Secondary antibodies were Alexa 594 goat
anti–rabbit and Alexa 488 goat anti–mouse. Coverslips were mounted in
GEL/MOUNT TM (Biomeda). Each fluorescence image was acquired using
a confocal laser scanning unit coupled to a Zeiss Axiovert S100 (Carl Zeiss
MicroImaging, Inc.).
Antibodies and other chemicals
An affinity-purified antibody (Ab62) raised against a  -catenin peptide cor-
responding to aa 434–530 was described previously (Lu et al., 1999), and
monoclonal  -catenin antibody was from Transduction Laboratories, Inc.
Polyclonal anticortactin antibody was from Santa Cruz Biotechnology,
Inc., monoclonal anti-MAP2 was from Chemicon, Inc., monoclonal antitu-
bulin was from Sigma-Aldrich. Monoclonal anti-HA antibody was from
Santa Cruz Biotechnology, Inc. Normal mouse IgG was from Santa Cruz
Biotechnology, Inc., and Alexa 594 goat anti–rabbit IgG, Alexa 488 goat
anti–mouse IgG, and Phalloidin 594 were from Molecular Probes, Inc.
PP2 (a Src family tyrosine kinase inhibitor with specificity for Fyn, Lck,
and Hck) and BDNF were purchased from Calbiochem and used at the
concentrations indicated in Results. NGF was purchased from Roche, Inc.
Plasmids
Cloning of full-length  -catenin in pEGFP vector (CLONTECH Laborato-
ries, Inc.) was described previously (Lu et al., 1999). Several  -catenin de-
letion constructs in pEGFP were generated by restriction digests:  C205
and  C332 using the NruI and StuI sites in  -catenin, respectively.  C99
construct was generated by PCR using the QuikChange
® Site-Directed Mu-
tagenesis kit (Stratagene) for introducing two-stop codons right after aa
number 1,148. FL   P6 lacking the polyproline track (219–224), was gen-
erated using the QuikChange
® Site-Directed Mutagenesis kit (Stratagene).
The fusion proteins for GST–SH3 domain of mouse Fyn (85–139) and Lck
(54–120) were from Santa Cruz Biotechnology, Inc. GST–mouse full-length
cortactin and GST–CT–cortactin (aa 287–509) were provided by Sheila
Thomas (Fred Hutchinson Cancer Research Center, Seattle, WA). Mouse
cortactin–Flag construct in pCDNA3 was provided by J.T. Parsons (Univer-
sity of Virginia Health Sciences Center, Charlottesville, VA). Human Fyn
and dominant-negative Fyn K299M constructs in pCMV5 vector were pro-
vided by Marilyn D. Resh (Memorial Sloan Kettering Cancer Center, New
York, NY). Plasmids corresponding to RhoV14 and C3 were provided by Jeff
Settleman (Massachusetts General Hospital, Charlestown, MA).
Immunoprecipitation and pull-down assays
For immunoprecipitation, cells were lysed in NP-40 buffer (10 mM Tris,
pH 7.4, 1 mM EDTA, 1 mM EGTA, 50 mM NaCl, and 0.5% NP-40), incu-
bated at 4 C for 30 min, and spun at 36,000 rpm for 30 min. Supernatants
were precleared with protein G beads and normal mouse IgG for 30 min at
4 C. After preclearing, lysates were incubated with antibody or normal
mouse IgG for 2 h. Protein G beads were added for an additional 2 h.
Complexes were washed in NP-40 buffer three times, eluted in 2   SDS
buffer, and loaded in SDS–polyacrylamide gels. For  -catenin immunopre-
cipitation, both monoclonal and polyclonal antibodies were used. For im-
munofluorescence and blotting, monoclonal  -catenin antibody was used.
GST–cortactin and GST–CT–cortactin were expressed in Escherichia
coli and purified in glutathione-sepharose beads (Amersham Biosciences)
by standard methods. Cell lysates in NP-40 buffer were incubated with
GST fusion proteins bound to glutathione sepharose beads at 4 C for 30
min and washed three times in NP-40 buffer. Beads were resuspended in
2   SDS buffer and loaded for SDS-PAGE.
Morphometry
The length of a particular process was measured by tracing a line from the
cell body to the end of the process with MetaMorph software. In the PC12
cells, primary processes were defined as those emerging from the cell body.
Secondary processes emerged from primary processes and were longer than
1.5  m. Three independent experiments were quantified in all cases.
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